Literature DB >> 29563540

Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis.

Monika L Burness1, Max S Wicha2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29563540      PMCID： PMC5939042          DOI： 10.1038/s41422-018-0028-4

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

1.  Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.

Authors:  Zhaoyi Wang; Xintian Zhang; Peng Shen; Brian W Loggie; Yunchao Chang; Thomas F Deuel
Journal:  Biochem Biophys Res Commun       Date:  2005-11-04       Impact factor: 3.575

2.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.

Authors:  Christine M Fillmore; Piyush B Gupta; Jenny A Rudnick; Silvia Caballero; Patricia J Keller; Eric S Lander; Charlotte Kuperwasser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

3.  Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2015-07-23       Impact factor: 79.321

4.  Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

Authors:  Liang Shi; Bin Dong; Zhongwu Li; Yunwei Lu; Tao Ouyang; Jinfeng Li; Tianfeng Wang; Zhaoqing Fan; Tie Fan; Benyao Lin; Zhaoyi Wang; Yuntao Xie
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

5.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

6.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Authors:  C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto
Journal:  Lancet       Date:  2011-07-28       Impact factor: 79.321

Review 7.  Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Authors:  Jack Cuzick; Ivana Sestak; Bernardo Bonanni; Joseph P Costantino; Steve Cummings; Andrea DeCensi; Mitch Dowsett; John F Forbes; Leslie Ford; Andrea Z LaCroix; John Mershon; Bruce H Mitlak; Trevor Powles; Umberto Veronesi; Victor Vogel; D Lawrence Wickerham
Journal:  Lancet       Date:  2013-04-30       Impact factor: 79.321

8.  ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells.

Authors:  Hao Deng; Xin-Tian Zhang; Mo-Lin Wang; Hong-Yan Zheng; Li-Jiang Liu; Zhao-Yi Wang
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

9.  Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.

Authors:  Jack Cuzick; Ivana Sestak; Simon Cawthorn; Hisham Hamed; Kaija Holli; Anthony Howell; John F Forbes
Journal:  Lancet Oncol       Date:  2014-12-11       Impact factor: 41.316

10.  Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells.

Authors:  Qiang Wang; Jun Jiang; Guoguang Ying; Xiao-Qing Xie; Xia Zhang; Wei Xu; Xuemin Zhang; Erwei Song; Hong Bu; Yi-Fang Ping; Xiao-Hong Yao; Bin Wang; Shilei Xu; Ze-Xuan Yan; Yanhong Tai; Baoquan Hu; Xiaowei Qi; Yan-Xia Wang; Zhi-Cheng He; Yan Wang; Ji Ming Wang; You-Hong Cui; Feng Chen; Kun Meng; Zhaoyi Wang; Xiu-Wu Bian
Journal:  Cell Res       Date:  2018-02-02       Impact factor: 25.617
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.